Related Experiment Video

Updated: Aug 18, 2026

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
06:39

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on: October 3, 2018

Pediatric myelodysplastic syndromes

Charlotte Marie Niemeyer1, Christian Peter Kratz, Henrik Hasle

  • 1Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, University of Freiburg, Mathildenstrasse 1, 79106 Freiburg, Germany. niemeyer@kikli.ukl.uni-freiburg.de

Current Treatment Options in Oncology
|May 5, 2005
PubMed

Insights

A new classification aids childhood myelodysplastic and myeloproliferative diseases diagnosis. Hematopoietic stem cell transplantation offers a cure for over half of affected children, making palliative care less critical.

Area of Science:

  • Pediatric Hematology
  • Oncology
  • Genetics

Background:

  • Childhood myelodysplastic and myeloproliferative diseases are uncommon.
  • A recent classification has improved diagnostic capabilities for these pediatric hematologic malignancies.

Purpose of the Study:

  • To highlight the impact of a new classification system on diagnosing pediatric myelodysplastic and myeloproliferative diseases.
  • To emphasize the curative potential of hematopoietic stem cell transplantation in affected children.
  • To explore the relevance of genetic factors in pediatric myelodysplastic syndrome and its connection to leukemogenesis.

Main Methods:

  • Review of the new classification system for pediatric myelodysplastic and myeloproliferative diseases.
  • Analysis of treatment outcomes, focusing on hematopoietic stem cell transplantation efficacy.
  • Discussion of current understanding of genetic predispositions in pediatric myelodysplastic syndrome.

Main Results:

  • The new classification has significantly simplified the diagnosis of these rare childhood disorders.
  • Hematopoietic stem cell transplantation demonstrates a high success rate, curing over 50% of pediatric patients.
  • Palliative strategies common in adult myelodysplastic syndrome are less relevant for children due to transplantation's effectiveness.

Conclusions:

  • The updated classification is crucial for accurate diagnosis and management of pediatric myelodysplastic and myeloproliferative diseases.
  • Hematopoietic stem cell transplantation is a primary curative option for children with these conditions.
  • Investigating genetic factors in pediatric myelodysplastic syndrome may offer insights into broader leukemogenesis, including in adults.

More Related Videos

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation12:05

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation

Published on: November 3, 2018

Identifying Bone Marrow Microenvironmental Populations in Myelodysplastic Syndrome and Acute Myeloid Leukemia06:33

Identifying Bone Marrow Microenvironmental Populations in Myelodysplastic Syndrome and Acute Myeloid Leukemia

Published on: November 10, 2023

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...